Ixazomib as treatment for pyoderma gangrenosum associated with IgA smoldering multiple myeloma.
| Publicado en: | Annals of Hematology Vol. 101; no. 2; pp. 441 - 443 |
|---|---|
| Autores principales: | , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Feb2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=154567461&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 154567461 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 09395555 1WU jtl: Annals of Hematology issn: 09395555 maglogo: N pubinfo: dt: Feb2022 vid: 101 iid: 2 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 154567461 149822384 10.1007/s00277-021-04524-w 154567461 ppf: 441 ppct: 2 formats: tig: atl: Ixazomib as treatment for pyoderma gangrenosum associated with IgA smoldering multiple myeloma. aug: au: Cespedes, David Alvarez Gallitano, Stephanie M. Bhutani, Divaya affil: Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA sug: pubtype: Academic Journal doctype: Journal Article ougenre: Unknown ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|